The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pathologic complete response and breast cancer survival post-neoadjuvant chemotherapy: A systematic review and meta-analysis of real-world data.
 
Marcelo Antonini
No Relationships to Disclose
 
Andre Mattar
Employment - Novo Nordisk (I)
Leadership - Novo Nordisk (I)
Stock and Other Ownership Interests - Novo Nordisk; Novo Nordisk (I)
Consulting or Advisory Role - AstraZeneca; Exact Sciences; Fleury Group; Lilly; MSD Oncology; Novartis; Roche
Speakers' Bureau - Exact Sciences; Lilly; MSD Oncology; Novartis
Travel, Accommodations, Expenses - MSD Oncology; Roche
Other Relationship - Genomic Health; Roche
 
Thais Pereira
No Relationships to Disclose
 
Ludmila Oliveira
No Relationships to Disclose
 
Marina Teixeira
No Relationships to Disclose
 
Andressa Amorim
No Relationships to Disclose
 
Odair Ferraro
No Relationships to Disclose
 
Marcellus Ramos
No Relationships to Disclose
 
Francisco Pimentel Cavalcante
Honoraria - AstraZeneca
Consulting or Advisory Role - MSD Oncology; Pfizer; Roche
Speakers' Bureau - AstraZeneca/Daiichi Sankyo; Libbs; Pfizer; Roche
Research Funding - Roche (Inst)
 
Felipe Zerwes
Speakers' Bureau - AstraZeneca; LIBBS; MSD Oncology; Novartis
 
Marcelo Madeira
No Relationships to Disclose
 
Leonardo Soares
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca
Speakers' Bureau - MSD Oncology; Roche
Research Funding - BD Bard; Daiichi Sankyo/Astra Zeneca
Travel, Accommodations, Expenses - MSD Oncology
 
Eduardo Millen
Speakers' Bureau - Lilly
 
Antonio Frasson
Consulting or Advisory Role - AstraZeneca
 
Fabricio Brenelli
Speakers' Bureau - MSD Oncology
 
Gil Facina
No Relationships to Disclose
 
Renata Arakelian
No Relationships to Disclose
 
Marcela dos Santos
No Relationships to Disclose
 
Ruffo Freitas-Junior
Honoraria - Daiichi Sankyo/Astra Zeneca (Inst); Gilead Sciences (Inst); Libbs; Lilly (Inst); MSD; MSD/AstraZeneca; Novartis (Inst); zeiss
Consulting or Advisory Role - Gilead Sciences; MSD Oncology; Novartis
Research Funding - AstraZeneca (Inst); Gilead Sciences (Inst); MSD (Inst); Novartis Biociencias (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Daichii Sankyo; Gilead Sciences; Libbs; MSD/AstraZeneca
 
Luiz Gebrim
No Relationships to Disclose